Technical Report No. 26 (Revised 2025): Sterilizing Filtration of Liquids

NEW
Published
Nov 2025
ISBN
978-1-945584-53-4
Pages
105
PDA Item Number
43595

Premium Members: to claim your annual free technical document download, email membership@pda.org and indicate the document you wish to claim.

Format
PDF Single User
Member Price
$180.00
Nonmember Price
$325.00
Government Price
$180.00

*Premium members: Download your free copy by 12/5/2025!*

Sterilizing filtration is the process of removing microorganisms from a fluid stream without adversely affecting product quality (1-4). This technical report (TR) is intended to provide a systematic approach to selecting and validating the most appropriate filter for liquid sterilizing filtration applications.

PDA's original Technical Report No. 26: Sterilizing Filtration of Liquids, (TR-26) published in 1998 described the use and validation of sterilizing filtration to a generation of pharmaceutical scientists and engineers. A revision of the original report was developed in 2008 in response to enhancements in filtration technologies and recent additional regulatory requirements within the pharmaceutical industry at that time. This current revision has been implemented to reflect current best practices and regulatory expectations, as well as clarify the roles of filter suppliers and end-users. References are provided for scientific publications and international regulatory documents where more detail and supportive data may be found.

Table of Contents

  • 1.0 Introduction
  • 2.0 Glossary
  • 3.0 How Filters Work
  • 4.0 Filter Qualification, Design, and Characterization
  • 5.0 Filtration Process Design, Usage, and Handling Considerations
  • 6.0 Product and Process-Specific Validation Testing for Sterilizing Filtration
  • 7.0 Integrity Testing
  • 8.0 Sterilization of Filters
  • 9.0 References
  • 10.0 Appendix I: Diffusive Flow Theory
  • 11.0 Appendix II: Nondestructive Physical Integrity Test Methods
  • 12.0 Appendix III: Integrity Test Troubleshooting Guide
  • 13.0 Appendix References

About the Authors

  • Maik Jornitz,BioProcess Resources, LLC (Co-Lead)
  • William Peterson, Merck & Co., Inc., Rahway, NJ, USA (Co-Lead)
  • Holger Bromm, Sartorius
  • Steven Ensign, Eli Lilly & Company
  • Annie Leahy, MilliporeSigma
  • Morven McAlister,Cytiva
  • Leesa McBurnie, Meissner Corporation
  • Brian Thome, Biogen Inc.